Morabito Christopher — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Morabito Christopher is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Christopher Morabito is the Chief Medical Officer of Astria Therapeutics, Inc., as indicated in the SEC filing dated January 23, 2026 (CIK 0001859284). In this role, he leads medical strategy and clinical development for Astria, a biopharmaceutical company focused on rare allergic and immunological diseases, including preclinical programs STAR-0215 and STAR-0310. The filing shows no equity purchases or sales by Mr. Morabito at that time.
Role
Insider
Notability
45/100
Board memberships
Astria Therapeutics, Inc.
Awards & honors
Leads medical strategy and clinical development at Astria Therapeutics
Oversees preclinical programs STAR-0215 and STAR-0310
Supports regulatory strategy and translational medicine initiatives
Frequently Asked Questions
Who is Morabito Christopher?
Christopher Morabito is the Chief Medical Officer of Astria Therapeutics, Inc., as indicated in the SEC filing dated January 23, 2026 (CIK 0001859284). In this role, he leads medical strategy and clinical development for Astria, a biopharmaceutical company focused on rare allergic and immunological diseases, including preclinical programs STAR-0215 and STAR-0310. The filing sho…
Where can I see all of Morabito Christopher's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
